🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed fat-burning effects. Followers are urged to contact these accounts directly for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on Telegram, where groups with thousands of members share comparison photos, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Express Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in users injecting products of unknown origin.

Several experts said the popularity for the experimental drug could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the British medical regulations.

Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, marketing, and consumer laws, risking fines, prosecution or prison.

Service Reaction and Material Elimination

Based on the social media company, the platform has taken down violative material and prohibited related hashtags and query recommendations. The organization stated it was committed to maintaining the platform safe and allocating resources in strengthening compliance measures.

Online Trading Activities

Investigations also found groups with up to nine thousand participants marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, filled with photos of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at residence.

Within minutes of entering one community, a seller posted contact information, where most purchases take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, health issues or past usage.

Product Information and Pricing

Within these groups, messages show dark colored packages with Royal Mail stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with sterile water, or pre-filled pens typically sold at £160 for 20 milligrams. When asked how long a injector should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram said it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.

Her team has previously encountered individuals injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject patients to possibly significant medical dangers”.